DNA Synthesis Market Size, Share, Growth, Analysis, 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global DNA Synthesis Market Size Analysis

Global DNA Synthesis Market Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value

North America Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value
U.S.
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Instruments
    1. By Value
  3. Reagents & Consumables
    1. By Value
  4. Service
    1. By Value
  5. Oligonucleotide Synthesis
    1. By Value
  6. Gene Synthesis
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Research & Development
    1. By Value
  3. Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. RNAi Therapies
    1. By Value
  6. Antisense Oligonucleotide-based Therapies
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biopharmaceutical Companies
    1. By Value
  3. Diagnostic Companies
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. CROs & CDMOs
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value
U.K.
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Instruments
    1. By Value
  3. Reagents & Consumables
    1. By Value
  4. Service
    1. By Value
  5. Oligonucleotide Synthesis
    1. By Value
  6. Gene Synthesis
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Research & Development
    1. By Value
  3. Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. RNAi Therapies
    1. By Value
  6. Antisense Oligonucleotide-based Therapies
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biopharmaceutical Companies
    1. By Value
  3. Diagnostic Companies
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. CROs & CDMOs
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value
China
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Instruments
    1. By Value
  3. Reagents & Consumables
    1. By Value
  4. Service
    1. By Value
  5. Oligonucleotide Synthesis
    1. By Value
  6. Gene Synthesis
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Research & Development
    1. By Value
  3. Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. RNAi Therapies
    1. By Value
  6. Antisense Oligonucleotide-based Therapies
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biopharmaceutical Companies
    1. By Value
  3. Diagnostic Companies
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. CROs & CDMOs
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value
UAE
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Instruments
    1. By Value
  3. Reagents & Consumables
    1. By Value
  4. Service
    1. By Value
  5. Oligonucleotide Synthesis
    1. By Value
  6. Gene Synthesis
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Research & Development
    1. By Value
  3. Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. RNAi Therapies
    1. By Value
  6. Antisense Oligonucleotide-based Therapies
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biopharmaceutical Companies
    1. By Value
  3. Diagnostic Companies
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. CROs & CDMOs
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Instruments
  1. By Value
3. Reagents & Consumables
  1. By Value
4. Service
  1. By Value
5. Oligonucleotide Synthesis
  1. By Value
6. Gene Synthesis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Research & Development
  1. By Value
3. Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. RNAi Therapies
  1. By Value
6. Antisense Oligonucleotide-based Therapies
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biopharmaceutical Companies
  1. By Value
3. Diagnostic Companies
  1. By Value
4. Academic & Research Institutes
  1. By Value
5. CROs & CDMOs
  1. By Value
Brazil
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Instruments
    1. By Value
  3. Reagents & Consumables
    1. By Value
  4. Service
    1. By Value
  5. Oligonucleotide Synthesis
    1. By Value
  6. Gene Synthesis
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Research & Development
    1. By Value
  3. Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. RNAi Therapies
    1. By Value
  6. Antisense Oligonucleotide-based Therapies
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biopharmaceutical Companies
    1. By Value
  3. Diagnostic Companies
    1. By Value
  4. Academic & Research Institutes
    1. By Value
  5. CROs & CDMOs
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

DNA Synthesis Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific (US)
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
GenScript Biotech (China)
Integrated DNA Technologies (IDT) (US)
Twist Bioscience (US)
Eurofins Genomics (Germany)
Azenta Life Sciences (US)
Merck KGaA (Sigma-Aldrich) (Germany)
ATUM (US)
OriGene Technologies (US)
DNA Script (France)
Synbio Technologies (US)
Bioneer Corporation (South Korea)
Bio Basic Inc. (Canada)
Biomatik (Canada)
Quintara Biosciences (US)
Gene Universal (US)
Creative Biogene (US)

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Dhanashri B

Senior Research Associate